Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Nasacort AQ superior to or preferred over other allergy medications

Nov. 15, 1996

Sandoz OTC medications approved for cold symptoms

Nov. 15, 1996

Senju reports new compounds for treating allergic disorders

Nov. 15, 1996

Genzyme licenses vectors for CF gene therapy from Vical

Nov. 8, 1996

Natural PAF acetyltransferase inhibitor as lead antiinflammatory compound

Nov. 8, 1996

Warner-Lambert claims NK3 antagonists with broad therapeutic applications

Nov. 8, 1996

Favorable results reported for Targeted Genetics' CF gene therapy

Nov. 1, 1996

UCSF scientists discover new gene therapy approach to CF

Nov. 1, 1996

R-Albuterol for pediatric asthma

Nov. 1, 1996

Nonpeptide NK1/NK2 antagonist identified by Merck & Co.

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...